Systemic cytokine response in humans with chiclero’s ulcers
- First Online:
- Cite this article as:
- Lezama-Davila, C.M. & Isaac-Marquez, A.P. Parasitol Res (2006) 99: 546. doi:10.1007/s00436-006-0203-2
- 59 Downloads
In this work, we report the existence of enhanced concentrations of IL-2 (Th1 cytokine), TNF-α (mainly a Th1 cytokine), IL-12p40, a strong delayed type hypersensitivity response, and the absence of a serum-specific antibody response (IgG or IgE) in patients with active chiclero’s ulcers. There was a low serum concentration of IL-6 (a Th2 cytokine) that was further reduced once patients healed following antimonial therapy (i.e., 4 months after treatment started). There was an absence of serum IL-4 (a Th2 cytokine) in patients before and after healing. The serum content of nitric oxide, transforming growth factor-β1, and IL-12p70 in patients with progressive chiclero’s ulcers was not different from that of controls. Patients had an alteration in blood-cell counts and showed a poor T cell proliferation after in vitro stimulation with Leishmania mexicana gp63. We concluded that patients with progressive chiclero’s ulcers develop a Th1 type of response at this stage of the disease which correlates with increases in circulating eosinophils and B cells and a reduction of circulating CD8+ T lymphocytes.